In situ hydrogel: Different approaches to ocular drug delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 2, 2013, Pages 27-36

  Gambhire, Savita ^a   Bhalerao, Karuna ^a   Singh, Sushma ^a  

^a Dr L H Hiranandani College of Pharmacy   (India)

Author keywords

In situ gel; Ion triggered; PH triggered; Temperature triggered

Indexed keywords

ACECLOFENAC; ALGINIC ACID; ALUMINUM MAGNESIUM SODIUM SILICATE; BAICALIN; CARBOXYMETHYLCELLULOSE; CIPROFLOXACIN; DICLOFENAC; ETHYL CELLULOSE; FLUCONAZOLE; GELLAN; INDOMETACIN; ION; KETOROLAC; LEVOFLOXACIN; MACROGOL; MOXIFLOXACIN; OFLOXACIN; POLOXAMER; POLYACRYLIC ACID;

ANATOMY; BLOOD EYE BARRIER; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG RELEASE; DRUG STABILITY; EYE; FLOW KINETICS; GELATION; GELLING CAPACITY; GELLING TIME; HUMAN; HYDROGEL; IN SITU HYDROGEL; LACRIMAL FLUID; PATENT; PH; PHYSICAL PHENOMENA; REVIEW; SOL GEL TRANSITION TEMPERATURE; TEMPERATURE;

EID: 84875941224     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Mehta Markand, Shah Viral, Upadhyay U.M., Opthalmic Drug Delivery with Emphasis on in Situ Gel System: A Review, IJPI's Journal of Pharmaceutics and Cosmetology, Vol 2: 7 (2011),52-67.
2. Jitendra, Sharma P.K. Banik A. And Dixit S., A New Trend: Ocular Drug Delivery System, Pharma Science Monitor, International Journal Of Pharmaceutical Sciences, Vol-2, Issue-3, July-2011, 1-25.
3. ndEdition, (2005), 271-272.
4. D.M. Maurice, S. Mishima, Ocular pharmacokinetics, in: M.L. Sears (Ed.), Handbook of experimental pharmacology, vol. 69, Springer Verlag, Berlin-Heidelberg, 1984, 16-119.
5. Escobar-Chavez J. J., Lopez-Cervantes M., Naïk A., Kalia Y. N, Quintanar-Guerrero D, Ganem-Quintanar A., Applications Of Thermo Reversible Pluronic F-127gels In Pharmaceutical Formulations Pharm Pharmaceutics Sci (www. cspsCanada.org) 9 (3):,(2006), 339-358.
6. Nanjawade B.K., Manvi F.V., Manjapa A. S., "In situ forming hydro gels for sustained ophthalmic drug delivery", journal of controlled release, 122(2007),119-134.
7. H. B Nirmal, S. R Bakliwal., S. P Pawar., In-Situ gel: New trends in Controlled and Sustained Drug Delivery System, International Journal of PharmTech Research, Vol.2, No.2, pp 1398-1408, April-June (2010), 1398-1408.
8. Ding S. "Recent development in ophthalmic drug delivery", pstt, vol-1, (1998);8-9.
9. Kaur I. P, Kanwar M. "Ocular preparation: the formulation approach". Drug Devel Indust Pharm. (2002); 28: 373.
10. Hazare A. A, Mali M. N, "In situ forming system for sustained ocular drug delivery", European Industrial Pharmacy,(2010), 17-20.
11. thEdition, Marcel Dekker,(2006), 680.
12. Pepas N.A., Bures P. Leobandung W., Ichikawa H. " Hydrogels in pharmaceutical formulations" European Journal of Pharmaceutics and Biopharmaceutics, 50, (2000) 27-46.
13. Rathore K.S., Insitu Gelling Ophthalmic Drug Delivery System: An Overview, International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 2, Suppl 4, (2010)30-34.
14. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev, (2001);53:321-39.
15. Bromberg LE, Ron E.S., "Temperature-responsive gels and thermo gelling polymer matrices for Protein and peptide delivery". Adv Drug Delivery, 1998; 31:197-221.
16. Wen-Di Ma, Hui Xu, Chao Wang, Shu-Fang Nie, Wei-San Pan, Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system, International Journal of Pharmaceutics (350), (2008);247-256.
17. Nittur Jayaprakash Rajas*, Kunchu Kavitha, Theetha Gounder, Tamizh Mani, in situ ophthalmic gels: a developing trend, International Journal of Pharmaceutical Sciences Review and Research Volume 7, 2011 Issue 1; Article-002.
18. S. Miyazaki, F. Suisha, N. Kawasaki, M. Shirakawa, K. Yamatoya, D. Attwood, Thermally reversible xyloglucan gels as vehicles for rectal drug delivery, Journal of control release, {56}, (1998);75-83.
19. S. Miyazaki, S. Suzuki, N. Kawasaki, K. Endo, A. Takahashi, D. Attwood, In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride, Int. J. Pharm. 229, (2001) 29-36.
20. H. Ibrahim, C. Bindschaedler, E. Doelker, P. Buri and R. Gurny "Concept and development of ophthalmic pseudo-latexes triggered by pH", International Journal of Pharmaceutics, 77, (1991). 211-219.
21. B. srividya, Rita M. Cardoza P., D. Ami, Sustained ophthalmic delivery of loxacin from a PH triggered in situ gelling system, Journal of control release,73,205-215. (2001).
22. K Ravindra Reddy, M. Ravi Shankar, Yadav and P. Sabitha reddy preparation and evaluation of Aceclofenac ophthalmic in situ gels. Journal of chemical. Biological and physical science, vol-1, no.-2, Sec.-B, (2011), 289-298.
23. Hanan M. El. Laithy, Pemiana L., Nesseem, M., Evaluation of two in situ gelling systems for ocular delivery of Moxifloxacin:In vitro and in vivo studies, Journal of Chemical and Pharmaceutical Research, 2011, 3(2):66-79.
24. Mohanambal E., Arun K. and Abdul Hasan Sathali A., Formulation and Evaluation of pH-triggered in situ Gelling System of Levofloxacin, Indian Journal of Pharmaceutical Education and Research, Vol-45, Issue 1,(2011).
25. Sirish Vodithala1*, Sadhna Khatry1, Nalini Shastri 1, M. Sadanandam1, "Formulation And Evaluation Of Ion Activated Ocular Gels Of Ketorolac Tromethamine", International Journal of Current Pharmaceutical Research, Vol 2, Issue 3, (2010).
26. J. Padma Preetha, K. Karthika, Rekha. NR and Khalid Elshafie, " Formulation and evaluation of in situ ophthalmic gels of Diclofenac sodium", Journal of Chemical and Pharmaceutical Research, 2(3) (2010):528-535.
27. Taís Gratieri, Guilherme Martins Gelfuso, Osvaldo de Freitas, Eduardo Melani Rocha, Renata F.V. Lopez, Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel, European Journal of Pharmaceutics and Biopharmaceutics, 79, (2011),320-327.
28. Haoyun Wu, Zhidong Liu, Junjie Peng, Lin Li, Nan Li, Jiawei Li, Hao Pan, "Design and evaluation of baicalin-containing in situ pH-triggered gelling system For sustained ophthalmic drug delivery", International Journal of Pharmaceutics, 410, (2011),31-40.
29. J. K Pandit, D Bharathi, A Srinatha, DN Ridhurkar, S Singh, "Long acting ophthalmic formulation of indomethacin: Evaluation of alginate gel systems", Indian journal of pharmaceutical science, Volume: 69, Issue: 1, (2007), 37-40.
30. J. Varshosaz, M. Tabbakhian and Z. Salmani, Designing of a Thermosensitive Chitosan/Poloxamer In Situ Gel for Ocular Delivery of Ciprofloxacin, The Open Drug Delivery Journal, 2, 61-70.,(2008).
31. D.M. Maurice, S. Mishima, Ocular pharmacokinetics, in: M.L. Sears (Ed.), Handbook of experimental pharmacology, vol. 69, Springer Verlag, Berlin-Heidelberg, 1984, pp. 16-119.
32. M. Hornof, E. Toropainen, A. Urtti, Cell culture models of the ocular barriers, Eur. J. Pharm. Biopharm. 60 (2005) 207-225.
33. Urtti, L. Salminen, Minimizing systemic absorption of topically administered ophthalmic drugs, Surv. Ophthalmol. 37(1993) 435-457.
34. Urtti, L. Salminen, O. Miinalainen, Systemic absorption of ocular pilocarpine is modified by polymer matrices, Int. J. Pharm.23 (1985) 147-161.
35. Urtti, H. Rouhiainen, T. Kaila, V. Saano, Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans, Pharm. Res. 11 (1994) 1278-1282.
36. Urtti, J.D. Pipkin, G.S. Rork, T. Sendo, U. Finne, A.J. Repta, Controlled drug delivery devices for experimental ocularstudies with timolol. 2. Ocular and systemic absorption inrabbits, Int. J. Pharm. 61 (1990) 241-249.
37. H.S. Huang, R.D. Schoenwald, J.L. Lach, Corneal penetration behavior of beta-blockers, J. Pharm. Sci. 72 (1983) 1272-1279.
38. M.R. Prausnitz, J.S. Noonan, Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to theeye, J. Pharm. Sci. 87 (1998) 1479-1488.
39. K.M. Hämäläinen, K. Kontturi, L. Murtomäki, S. Auriola, A. Urtti, Estimation of pore size and porosity of biomembranes from permeability measurements of polyethylene glycols using an effusion-like approach, J. Control. Release 49 (1997) 97-104.
40. D.H. Geroski, H.F. Edelhauser, Transscleral drug delivery for posterior segment disease, Adv. Drug Deliv. Rev. 52 (2001),37-48.
41. Robert Gurny, Tor Boye and Houssam lbrahim, "Ocular Therapy With Nanoparticulate Systems For Controlled Drug Delivery", Journal of Controlled Release, 2,(1985),353-361.
42. thmarch2012
43. Eaga Chandra Mohan, Jagan Mohan Kandukuri, Venkatesham Allenki, Preparation and Evaluation of In-Situ-Gels for Ocular Drug Delivery, Journal of Pharmacy Research, 2(6), 2009,1089-1094.
44. Stability Testing Of New Drug Substances and Products, Q1a (R2)